{"transactions":[{"id":3385189,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Notes","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"exercise","acquired":false,"price":0,"reported_value":358090.1,"ownership":{"direct":false,"nature":"By Medicxi Growth Co-Invest I LP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15.2,"expiration_date":"2020-05-07","underlying":"Common Stock","underlying_shares":23558},"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}},{"id":3385188,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Notes","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"exercise","acquired":false,"price":0,"reported_value":15073416.76,"ownership":{"direct":false,"nature":"By Medicxi Growth I LP"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Held by Medicxi Growth I LP (\"Medicxi Growth I\"). Medicxi Growth I GP Limited (\"Medicxi Growth I GP\") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited (\"Medicxi Manager\") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP (\"Medicxi Growth Co-Invest I\"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15.2,"expiration_date":"2020-05-07","underlying":"Common Stock","underlying_shares":991672},"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}},{"id":3385187,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"purchase","acquired":true,"shares":24426,"price":19,"value":464094.0,"ownership":{"direct":false,"nature":"By Medicxi Growth Co-Invest I LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":47984,"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}},{"id":3385186,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"purchase","acquired":true,"shares":1028205,"price":19,"value":19535895.0,"ownership":{"direct":false,"nature":"By Medicxi Growth I LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Held by Medicxi Growth I LP (\"Medicxi Growth I\"). Medicxi Growth I GP Limited (\"Medicxi Growth I GP\") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited (\"Medicxi Manager\") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP (\"Medicxi Growth Co-Invest I\"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":2019877,"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}},{"id":3385185,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"exercise","acquired":true,"shares":23558,"price":15.2,"value":358081.6,"ownership":{"direct":false,"nature":"By Medicxi Growth Co-Invest I LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":23558,"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}},{"id":3385184,"issuer":{"id":5177,"kind":"organization","name":"Phathom Pharmaceuticals, Inc.","symbol":"PHAT"},"owners":[{"id":154156,"kind":"person","name":"Edwards Jonathan S.","position":1,"cik":"0001791944","reported_name":"Edwards Jonathan S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T17:05:58.000Z","date":"2019-10-29","kind":"exercise","acquired":true,"shares":991672,"price":15.2,"value":15073414.4,"ownership":{"direct":false,"nature":"By Medicxi Growth I LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Held by Medicxi Growth I LP (\"Medicxi Growth I\"). Medicxi Growth I GP Limited (\"Medicxi Growth I GP\") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited (\"Medicxi Manager\") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP (\"Medicxi Growth Co-Invest I\"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose."}],"balance_after":991672,"source":{"system":"sec-edgar","filing":"0001209191-19-054530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783183/000120919119054530/doc4.xml","form_type":"4"}}]}